Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

MDGL – Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals, Inc.
MDGL
$432.60
Name : Madrigal Pharmaceuticals, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $10,049,107,968.00
EPSttm : -5.85
finviz dynamic chart for MDGL
Madrigal Pharmaceuticals, Inc.
$432.60
0.04%
$0.19
MDGL — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

10.13

Margin Of Safety %

Put/Call OI Ratio

0.44

EPS Next Q Diff

-2.22

EPS Last/This Y

10.85

EPS This/Next Y

11.63

Price

432.31

Target Price

690.44

Analyst Recom

1.19

Performance Q

-19.32

Upside

-148.4%

Beta

-0.99

Ticker: MDGL




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-10-12MDGL467.010.420.1814345
2026-10-13MDGL452.20.411.8014557
2026-10-14MDGL459.750.420.4214824
2026-10-15MDGL459.830.420.4015141
2026-10-16MDGL449.350.410.7815141
2026-10-19MDGL4470.470.1411608
2026-10-20MDGL467.70.470.3411737
2026-10-21MDGL458.120.460.1411972
2026-10-22MDGL453.280.469.9912007
2026-10-23MDGL433.830.470.1912129
2026-10-26MDGL437.420.471.4412195
2026-10-27MDGL440.750.471.4212389
2026-10-28MDGL431.420.470.1712387
2026-10-29MDGL431.590.473.1712533
2026-10-30MDGL430.170.470.0412583
2026-11-02MDGL430.830.472.9012629
2026-11-03MDGL396.060.541.2113515
2026-11-04MDGL400.730.460.2214059
2026-11-05MDGL400.770.440.1114952
2026-11-06MDGL400.240.431.3015150
2026-11-09MDGL432.830.440.6815327
2026-11-10MDGL433.60.440.9615751
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-10-12MDGL466.7578.1- -6.49
2026-10-13MDGL452.1278.1- -6.49
2026-10-14MDGL459.9078.1- -6.49
2026-10-15MDGL459.4578.1- -6.49
2026-10-16MDGL449.7578.1- -6.49
2026-10-19MDGL447.1378.1- -6.49
2026-10-20MDGL447.1378.1- -6.49
2026-10-21MDGL467.4178.1- -6.49
2026-10-22MDGL453.2578.1- -6.49
2026-10-23MDGL433.7078.1- -6.49
2026-10-26MDGL437.4278.1- -6.49
2026-10-27MDGL440.7678.1- -6.49
2026-10-28MDGL431.2278.1- -6.49
2026-10-29MDGL431.2878.1- -6.49
2026-10-30MDGL430.1678.1- -6.49
2026-11-02MDGL430.8478.1- -6.49
2026-11-03MDGL396.0678.1- -6.49
2026-11-04MDGL400.7983.6- -6.49
2026-11-05MDGL400.5483.6- -6.49
2026-11-06MDGL399.8383.6- -6.49
2026-11-09MDGL432.8183.6- -6.49
2026-11-10MDGL432.31146.3- -2.00
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-10-12MDGL-1.40-1.8011.13
2026-10-13MDGL-1.41-1.8011.13
2026-10-14MDGL-1.41-1.8011.13
2026-10-15MDGL-1.41-1.8011.13
2026-10-16MDGL-1.41-1.8011.13
2026-10-19MDGL-1.41-1.7611.13
2026-10-20MDGL-1.41-1.7611.13
2026-10-21MDGL-1.41-1.7611.13
2026-10-22MDGL-1.41-1.7611.13
2026-10-23MDGL-1.41-1.7611.13
2026-10-26MDGL-1.41-2.7411.13
2026-10-27MDGL-1.41-2.7410.19
2026-10-28MDGL-1.41-2.7410.19
2026-10-29MDGL-1.41-2.7410.19
2026-10-30MDGL-1.41-2.7410.19
2026-11-02MDGL-1.41-2.7510.19
2026-11-03MDGL-1.41-2.7510.19
2026-11-05MDGL-1.41-2.7510.19
2026-11-06MDGL-1.40-2.7510.19
2026-11-09MDGL4.55-2.6210.13
2026-11-10MDGL4.55-2.6210.13
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS​

1.83

Avg. EPS Est. Current Quarter

1.19

Avg. EPS Est. Next Quarter

-0.39

Insider Transactions

4.55

Institutional Transactions

-2.62

Beta

-0.99

Average Sales Estimate Current Quarter

477

Average Sales Estimate Next Quarter

460

Fair Value

Quality Score

49

Growth Score

28

Sentiment Score

85

Actual DrawDown %

29.7

Max Drawdown 5-Year %

-61.4

Target Price

690.44

P/E

Forward P/E

60.34

PEG

P/S

7.04

P/B

16.02

P/Free Cash Flow

EPS

-5.98

Average EPS Est. Cur. Y​

-2

EPS Next Y. (Est.)

9.62

Target Price Estimates Raised

3

Target Price Estimates Lowered

Profit Margin

-10.89

Relative Volume

1.3

Return on Equity vs Sector %

-51.1

Return on Equity vs Industry %

-31.4

EPS 1 7Days Diff

4.5

EPS 1 30Days Diff

4.49

EBIT Estimation

◆ MDGL Healthcare
$432.60
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
0/20
Pullback
11/25
Volume
0/15
Valuation
15/20
TP/AR
3/10
Options
5/10
RSI
44.2
Range 1M
62.5%
Sup Dist
5.2%
🚀
Momentum Growth
Ride accelerating trends
N/A
40 /100
WEAK
Momentum
0/25
Growth
29/30
Estimates
3/20
Inst/Vol
2/15
Options
6/10
EPS Yr
84.3%
EPS NY
456%
52W%
30.9%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟡 HOLD +1.2% upside
Quality
6/30
Valuation
2/30
Growth
22/25
Stability
6/10
LT Trend
0/5
Upside
+1.2%
Quality
49
MDGL — P/E HistoricalBiotechnology
Madrigal Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 915
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
MDGL

Latest News

—
Caricamento notizie per MDGL…
stock quote shares MDGL – Madrigal Pharmaceuticals Inc Stock Price stock today
news today MDGL – Madrigal Pharmaceuticals Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MDGL – Madrigal Pharmaceuticals Inc yahoo finance google finance
stock history MDGL – Madrigal Pharmaceuticals Inc invest stock market
stock prices MDGL premarket after hours
ticker MDGL fair value insiders trading